{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:51Z","timestamp":1740144231759,"version":"3.37.3"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012248","name":"Collaborative Innovation Center for Modern Science and Technology and Industrial Development of Jiangxi Traditional Medicine","doi-asserted-by":"crossref","award":["No. JDZX2015216"],"award-info":[{"award-number":["No. JDZX2015216"]}],"id":[{"id":"10.13039\/501100012248","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Nonalcoholic fatty liver disease (NAFLD) is strongly associated with type 2 diabetes mellitus (T2DM), and low vitamin D levels are positively associated with NAFLD and T2DM. But there is absence of convincing evidence-based medicine to confirm the efficacy of vitamin D supplementation for T2DM with NAFLD. Thus, we aimed to conduct this meta-analysis to summarize the efficacy of vitamin D supplementation for T2DM combined with NAFLD, and help to further clarify its beneficial action on diabetic patients with NAFLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The study only selects clinical randomized controlled trials of vitamin D supplementation for T2DM combined with NAFLD. We will search each database from the built-in until July 2020. The English literature mainly searches Cochrane Library, Pubmed, EMBASE, and Web of Science. While the Chinese literature comes from CNKI, CBM, VIP, and Wangfang database. Meanwhile, we will retrieve clinical trial registries and grey literature. Two researchers worked independently on literature selection, data extraction, and quality assessment. The dichotomous data is represented by relative risk (RR), and the continuous is expressed by mean difference (MD) or standard mean difference (SMD), eventually the data is synthesized using a fixed effect model (FEM) or a random effect model (REM) depending on the heterogeneity. The imaging markers of liver, biomarkers of hepatic steatosis, serological indexes of hepatic fibrosis, serum NAFLD liver fat score were evaluated as the main outcomes. While several secondary outcomes were also evaluated in this study. The statistical analysis of this meta-analysis was conducted by RevMan software version 5.3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This meta-analysis will further determine the beneficial efficacy of vitamin D supplementation for T2DM combined with NAFLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study determines the positive efficacy of vitamin D supplementation for diabetic patients with NAFLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020148","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:36:50Z","timestamp":1588970210000},"page":"e20148","source":"Crossref","is-referenced-by-count":7,"title":["Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus"],"prefix":"10.1097","volume":"99","author":[{"given":"Shengju","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baochao","family":"Cai","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing 314001"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuke","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoran","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruili","family":"Wang","sequence":"additional","affiliation":[{"name":"Diabetes Department, Jintang County Traditional Chinese Medicine Hospital, Chengdu 610400, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072"},{"name":"Endocrinology Department, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing 314001"},{"name":"Diabetes Department, Jintang County Traditional Chinese Medicine Hospital, Chengdu 610400, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20240308","first-page":"253","article-title":"Nonalcoholic fatty liver disease: defining a common problem","volume":"9","author":"Gasbarrini","year":"2005","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R2-20240308","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.molmed.2006.10.001","article-title":"Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease","volume":"12","author":"Videla","year":"2006","journal-title":"Trends Mol Med"},{"key":"R3-20240308","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tem.2008.08.005","article-title":"Insulin resistance, inflammation, and non-alcoholic fatty liver disease","volume":"19","author":"Tilg","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"R4-20240308","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20240308","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J Hepatol"},{"key":"R6-20240308","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"(Suppl 1)","key":"R7-20240308","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1665-2681(19)31820-4","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)","volume":"8","author":"Bellentani","year":"2009","journal-title":"Ann Hepatol"},{"key":"R8-20240308","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Therap"},{"key":"R9-20240308","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/liv.13185","article-title":"Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?","volume":"36","author":"Valenti","year":"2016","journal-title":"Liver Int"},{"key":"R10-20240308","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/dc16-1787","article-title":"Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action","volume":"40","author":"Bril","year":"2017","journal-title":"Diabetes Care"},{"key":"R11-20240308","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome","volume":"22","author":"Kim","year":"2018","journal-title":"Clin Liver Dis"},{"key":"R12-20240308","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med"},{"key":"R13-20240308","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/hep.26183","article-title":"Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study","volume":"57","author":"Park","year":"2013","journal-title":"Hepatology (Baltimore, MD)"},{"key":"R14-20240308","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2337\/dc15-0140","article-title":"Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes","volume":"38","author":"Yamazaki","year":"2015","journal-title":"Diabetes Care"},{"key":"R15-20240308","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/liv.12851","article-title":"Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi\u2019an, China: a five-year cohort study","volume":"35","author":"Ming","year":"2015","journal-title":"Liver Int"},{"key":"R16-20240308","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.3748\/wjg.v21.i32.9607","article-title":"Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R17-20240308","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1586\/17474124.2016.1110018","article-title":"The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development \u2013 a potential therapeutic target?","volume":"10","author":"Dongiovanni","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R18-20240308","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1389557518666181025153712","article-title":"Association between vitamin D levels and nonalcoholic fatty liver disease: potential confounding variables","volume":"19","author":"Pacifico","year":"2019","journal-title":"Mini Rev Med Chem"},{"key":"R19-20240308","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3177\/jnsv.65.303","article-title":"Association between vitamin D status and non-alcoholic fatty liver disease: a population-based study","volume":"65","author":"Liu","year":"2019","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"R20-20240308","first-page":"g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ (Clinical research ed)"},{"key":"R21-20240308","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/archdischild-2014-307961","article-title":"What diseases are causally linked to vitamin D deficiency?","volume":"101","author":"Reid","year":"2016","journal-title":"Arch Dis Child"},{"key":"R22-20240308","doi-asserted-by":"crossref","first-page":"351385","DOI":"10.1155\/2010\/351385","article-title":"Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis","volume":"2010","author":"Alvarez","year":"2010","journal-title":"Int J Endocrinol"},{"key":"R23-20240308","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1093\/eurheartj\/eht166","article-title":"Vitamin D and cardiovascular disease: is the evidence solid?","volume":"34","author":"Al Mheid","year":"2013","journal-title":"Eur Heart J"},{"key":"R24-20240308","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3945\/ajcn.112.050013","article-title":"Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial","volume":"97","author":"Belenchia","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"R25-20240308","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/dom.12625","article-title":"Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial","volume":"18","author":"Forouhi","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"R26-20240308","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3945\/ajcn.111.011684","article-title":"Effects of vitamin D and calcium supplementation on pancreatic (cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial","volume":"94","author":"Mitri","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R27-20240308","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4254\/wjh.v6.i12.901","article-title":"Vitamin D deficiency in chronic liver disease","volume":"6","author":"Iruzubieta","year":"2014","journal-title":"World J Hepatol"},{"key":"R28-20240308","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3350\/cmh.2016.22.1.146","article-title":"The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease","volume":"22","author":"Chung","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"R29-20240308","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/apt.12377","article-title":"Meta-analysis: vitamin D and non-alcoholic fatty liver disease","volume":"38","author":"Eliades","year":"2013","journal-title":"Aliment Pharmacol Therap"},{"key":"R30-20240308","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1507\/endocrj.EJ12-0387","article-title":"High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome","volume":"60","author":"Rhee","year":"2013","journal-title":"Endocr J"},{"key":"R31-20240308","first-page":"g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ (Clinical research ed)"},{"key":"R32-20240308","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R33-20240308","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"R34-20240308","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/nu11030705","article-title":"Non-alcoholic fatty liver disease and risk of incident type 2 diabetes: role of circulating branched-chain amino acids","volume":"11","author":"van den Berg","year":"2019","journal-title":"Nutrients"},{"key":"R35-20240308","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ejcn.2011.118","article-title":"Vitamin D and type 2 diabetes: a systematic review","volume":"65","author":"Mitri","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"R36-20240308","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.numecd.2006.04.002","article-title":"Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease","volume":"17","author":"Targher","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R37-20240308","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1017\/S0007114511006830","article-title":"Effect of vitamin D 3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats","volume":"108","author":"George","year":"2012","journal-title":"Br J Nutr"},{"key":"R38-20240308","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hep.24737","article-title":"Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation","volume":"55","author":"Roth","year":"2012","journal-title":"Hepatology (Baltimore, MD)"},{"key":"R39-20240308","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/liv.12122","article-title":"1,25-dihydroxyvitamin D3 and its nuclear receptor repress human \u03b11 (I) collagen expression and type I collagen formation","volume":"33","author":"Potter","year":"2013","journal-title":"Liver Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:15:21Z","timestamp":1709928921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020148"}},"subtitle":["A protocol for a systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":39,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020148","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}